Inducible resistance to clindamycin in Staphylococcus aureus: Validation of Vitek-2 against CLSI D-test

Pathology

Volumn 45, Issue 2, 2013, Pages 181-184

  Gardiner, B J ^a,b   Grayson, M L ^a,c   Wood, G M ^a,b  

^a Austin Health   (United States)

^b Microbiology Department   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

D test; Inducible clindamycin resistance; Staphylococcus aureus

Indexed keywords

EID: 84873859337     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32835cccda     Document Type: Article

References (22)

1. th ed. London: Edward Arnold, 2010; Chapter 79, Lincomycin and clindamycin.
2. Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191: 368-73.
3. O'Brien FG, Lim TT, Chong FN, et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 2004; 42: 3185-90.
4. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of Antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007; 195: 202-11.
5. Murray P, editor. Manual of Clinical Microbiology. 9th ed. Washington: ASM Press, 2007; Chapter 74, Special phenotypic methods for detecting antibacterial resistance.
6. Weisblum E, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 1969; 98: 447-52.
7. Lewis JS II, Jorgensen JH. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40: 280-5.
8. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. M100-S22. Wayne, PA: CLSI, 2012; 32.
9. Fernandes CJ, O'Sullivan MVN, Cai Y, et al. Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol 2007; 45: 4018-20.
10. Swenson JM, Brasso WB, Ferraro MJ, et al. Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells. J Clin Microbiol 2007; 45: 3954-7.
11. bioMérieux. Vitek 2 AST-P612 Product Information. Ref 22-359. Marcy, l'Etoile, France: bioMérieux.
12. Nimmo G, Pearson J, Collignon P, Christiansen K, Coombs G, Bell J, McLaws ML. Staphylococcus aureus Survey 2011 Antimicrobial Susceptibility Report (SAP 2011). Perth: Australian Group on Antimicrobial Resistance (AGAR), 2011. www.agargroup.org
13. Tang P, Low DE, Atkinson S, et al. Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 system: comparison with results obtained with the Vitek-2 and Phoenix systems. J Clin Microbiol 2003; 41: 4823-5.
14. Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol 2004; 42: 1800-2.
15. BD Diagnostics. Phoenix BDXpert User's Manual. Sparks, MD: BD Diagnostics.
16. Buchan BW, Anderson NW, Ledeboer NA. Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolidelincosamide-streptogramin B resistance among clinical isolates of Staphylococcus. Diagn Microbiol Infect Dis 2012; 72: 291-4.
17. Steward CD, Raney PM, Morrell AK, et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 2005; 43: 1716-21.
18. Lavallée C, Rouleau D, Gaudreau C, et al. Performance of an agar dilution method and a Vitek 2 Card for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol 2010; 48: 1354-7.
19. Jethwani UN, Mulla SA, Shah LN, Panwala TR. Detection of inducible clindamycin resistance by an automated system in a tertiary care hospital. Afr J Microbiol Res 2011; 5: 2870-2.
20. Sharp S, Weber K, Bennett K. Detection of inducible clindamycin resistance, mecA-mediated oxacillin resistance, and vancomycin resistance with the Vitek 2 GP67 card as compared to the D-test, and cefoxitin and vancomycin disk diffusion testing in clinically significant isolates of Staphylococcus aureus. 109th General Meeting of the American Society of Microbiology, May 17-21, 2009, Philadelphia PA, USA. Abstr C-007.
21. Griffith R, Messina-Powell S, Creely D, et al. A new vancomycin test and inducible clindamycin resistance test for gram-positive organisms with the Vitek-2 systems. 107th General Meeting of the American Society of Microbiology, May 21-25, 2007, Toronto, Canada. Abstr C-014.
22. Nakasone I, Kinjo T, Yamane N, Kisanuki K, Shiohira CM. Laboratorybased evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing. Diagn Microbiol Infect Dis 2007; 58: 191-8.